Study Reveals Long COVID Leaves Distinct Immune Signature in Blood
A recent study published in Communications Medicine has identified distinct immune signatures in individuals suffering from long COVID, a condition where symptoms persist months after initial infection with SARS-CoV-2. Researchers from Australia and Norway conducted the study, which involved analyzing blood samples from participants in Victoria, Australia. The study focused on inflammatory and neurological protein levels, comparing those with long COVID to individuals who had recovered from COVID-19 and those who were SARS-CoV-2-naive. Key findings include elevated levels of interleukin-20 (IL-20) in long COVID patients, indicating ongoing inflammation. The study also found that vaccination did not exacerbate inflammation in these individuals, and protein levels either stabilized or decreased post-vaccination. However, the study was exploratory and small, necessitating further research for validation.